1998
Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance
Wainberg M, Friedland G. Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance. JAMA 1998, 279: 1977-1983. PMID: 9643862, DOI: 10.1001/jama.279.24.1977.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusDrug-resistant variantsDrug-resistant virusesHIV drug resistanceAntiviral therapyPublic health implicationsDrug resistanceGenital secretionsHealth implicationsPublic health importanceAntiretroviral therapyViral burdenAntiretroviral agentsPatient adherenceTreatment failureViral loadImmunodeficiency virusResistant virusesSustained reductionHealth importanceTherapyVirusChild routeBloodSecretion
1989
Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus.
Schrager L, Friedland G, Maude D, Schreiber K, Adachi A, Pizzuti D, Koss L, Klein R. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1989, 2: 570-5. PMID: 2555473.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHuman papillomavirus infectionPapillomavirus infectionImmunodeficiency virusLower genital tract neoplasiaGenital HPV infectionGenital tract neoplasiaSquamous cell abnormalitiesHPV infectionSquamous abnormalitiesHIV infectionHigh prevalenceCytological abnormalitiesNeoplastic disordersCervicovaginal smearsHigh riskCell abnormalitiesBlinded fashionInfectionWomenAbnormalitiesCellular changesFurther studiesVirusRisk